...
首页> 外文期刊>Ticks and tick-borne diseases >Transient sinus bradycardia during the course of Crimean-Congo hemorrhagic fever in children
【24h】

Transient sinus bradycardia during the course of Crimean-Congo hemorrhagic fever in children

机译:儿童克里米亚-刚果出血热过程中的短暂性窦性心动过缓

获取原文
获取原文并翻译 | 示例

摘要

Crimean-Congo hemorrhagic fever (CCHF) is an acute tick-borne viral zoonotic disease which is endemic in Turkey. Bradycardia has been reported among pediatric and adult patients with CCHF. But, it remains unclear, whether bradycardia is associated with ribavirin treatment or the severity of CCHF. In this study 26 hospitalized CCHF patients were reviewed in terms of age, gender, history of tick bite, duration of hospitalization, presence of bradycardia, laboratory features, ribavirin treatment, and blood products requirement. The demographic, clinical, laboratory and treatment characteristics of CCHF patients with or without bradycardia were compared. The mean age of the patients was 126.42 +/- 48.21 months. There were 8 female and 18 male patients. Sinus bradycardia was noted in 15 patients (mean age was 120.20 +/- 50.59 months, 5 female). Ribavirin had been administered 18 (69.2%) patients and 11 of them had bradycardia. There was not statistically significant relationships between bradycardia and ribavirin treatment (p = 0.683). Furthermore the occurrence of bradycardia was not associated with disease severity according to Swanepoel severity criteria (p = 0.683). We concluded that independent of the disease severity and the ribavirin treatment, transient sinus bradycardia might occur during the clinical course of CCHF in pediatric patients. For this reason clinicians should be aware of this finding and all CCHF patients should be monitored closely. (C) 2014 Elsevier GmbH. All rights reserved.
机译:克里米亚-刚果出血热(CCHF)是一种由tick传播的急性病毒性人畜共患病,在土耳其很流行。小儿和成年CCHF患者中有心动过缓的报道。但是,尚不清楚心动过缓是否与利巴韦林治疗或CCHF的严重程度有关。在这项研究中,对26例住院的CCHF患者进行了年龄,性别,of叮咬史,住院时间,心动过缓的存在,实验室特征,利巴韦林治疗和血液制品需求方面的回顾。比较了有或没有心动过缓的CCHF患者的人口统计学,临床,实验室和治疗特征。患者的平均年龄为126.42 +/- 48.21个月。男8例,女8例。 15例患者出现窦性心动过缓(平均年龄为120.20 +/- 50.59个月,女5例)。利巴韦林已被给予18(69.2%)位患者,其中11位患有心动过缓。心动过缓和利巴韦林治疗之间无统计学意义的相关性(p = 0.683)。此外,根据Swanepoel严重程度标准,心动过缓的发生与疾病严重程度无关(p = 0.683)。我们得出的结论是,与疾病严重程度和利巴韦林治疗无关,儿科患者CCHF的临床过程中可能会发生短暂性窦性心动过缓。因此,临床医生应注意这一发现,并应密切监视所有CCHF患者。 (C)2014 Elsevier GmbH。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号